• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

AliveCor Receives FDA Clearance of Next-Gen EKG Algorithms

by Jasmine Pennic 11/23/2020 Leave a Comment

AliveCor Receives FDA Clearance of Next-Gen EKG Algorithms

What You Should Know:

– AliveCor announced they received FDA clearance of new algorithms for use with their personal EKG devices, KardiaMobile and KardiaMobile 6L. These additional determinations will be available via a software upgrade for the Kardia devices in 2021.

– The additional FDA-cleared algorithms double the number of heart rhythm disturbances that AliveCor’s Kardia devices can detect, broadening the number of patients who are able to use their remote monitoring devices.


AliveCor, an AI-based personal ECG technology and provider of enterprise cardiology solutions, today announced that the US FDA had given clearance to the company’s next generation of interpretive ECG algorithms. AliveCor’s KardiaMobile and KardiaMobile 6L devices, along with the Kardia app, allow users to take a 30-second ECG and receive instant determinations of multiple cardiac conditions.

Why It Matters

This new FDA clearance positions AliveCor to deliver AI-based remote cardiological services for the vast majority of cases when cardiac patients are not in front of their doctor. AliveCor’s goal is to help cardiologists efficiently provide the best possible 24/7 service to their patients.

New Generation of AI-Powered Remote Cardiology

This new FDA 510(K) clearance provides detail and fidelity unlike any previously seen in personal ECG devices including:

– A “Sinus Rhythm with Premature Ventricular Contractions (PVCs)” determination if two or more ventricular ectopic beats are detected. PVCs are a common occurrence where extra heartbeats originate in the bottom chamber of the heart and occur sooner than the next expected regular heartbeat. After the PVC beat, a pause usually occurs, which causes the next normal heartbeat to be more forceful. When one feels the heart “skip a beat,” it is this more forceful beat that is felt.

– A “Sinus Rhythm with Supraventricular Ectopy (SVE)” determination if narrow-complex ectopy, such as premature atrial contractions (PACs), are detected. PACs are similar to PVCs, but these beats originate in the top chamber of the heart, however not in the heart’s natural pacemaker, the Sinus Node.

– A “Sinus Rhythm with Wide QRS,” determination for QRS intervals of 120ms or longer.  Wide QRS indicates that the activation of the bottom chamber of the heart is taking longer than expected. This could indicate a bundle branch block in which there is a delay in the passage of heart’s electrical signals along the bottom of the heart.

– A reduced number of “Unclassified” readings, thereby giving users more reliable insight into their heart rhythms.

– Improved sensitivity and specificity on the company’s “Normal” and “Atrial Fibrillation” algorithms, giving users fewer false positives, fewer false negatives, and even greater confidence in Kardia determinations.

– New visualizations, including average beat, PVC identification, and a tachogram.

“Kardia AI V2 is the most sophisticated AI ever brought to personal ECG,” said AliveCor CEO Priya Abani. “This suite of algorithms and visualizations will provide the platform for delivery of new consumer and professional service offerings beyond AFib, by allowing a much wider range of cardiac conditions to be determined on a personal ECG device.”

Availability

Today, KardiaMobile and KardiaMobile 6L are the most clinically validated personal ECG devices in the world, and provide instant detection of Normal Sinus Rhythm, Atrial Fibrillation, Bradycardia, and Tachycardia. The new determinations and services will be available in 2021.

RELATED:   IoMT Is Improving Patient Access: We Must Avoid Creating New Barriers

Tagged With: AI, algorithms, AliveCor, Artificial Intelligence, Atrial Fibrillation, ecg, EKG Medical Devices, FDA, FDA Clearance, Heart, PACS

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« Signify Health Acquires Healthcare Payment Blockchain Company PatientBlox
SPAC Merges with 2 Telehealth Companies to Form Public Digital Health Company in $1.35B Deal »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • Hurdle Secures $5M for Digital Mental Health Platform for People of Color

    Hurdle Secures $5M for Digital Mental Health Platform for People of Color

    ... more
  • West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution Deployment

    West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution

    ... more
  • Onyx, AMA Innovations Form Collaboration to Build FHIR-Based Messaging

    Onyx, AMA Innovations Form Collaboration to Build FHIR-Based Messaging

    ... more
  • op 5 business opportunities for digital health companies in 2021. Where is the money?

    Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?

    ... more

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • Intelligent Automation of the Revenue Cycle: How an Integrated Platform Approach Yields Financial Results Intelligent Automation of the Revenue Cycle: How an Integrated Platform Approach Yields Financial Results
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 22 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution Deployment West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution
  • op 5 business opportunities for digital health companies in 2021. Where is the money? Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |